FDA Commissioner Marty Makary stated publicly: "We are paying close attention to misleading claims being made by telehealth and pharma companies across all media platforms." The regulatory environment around GLP-1-adjacent products is tightening
Mounjaro, which also contains the same active ingredient, tirzepatide, was FDA-approved in 2022, for managing blood sugar levels in adults with type 2 diabetes
Both reduced alcohol use
FIGURE 11 Further, like GLP-1, the C-terminal amino acids of SR18 also interact with the N-terminal region of GLP-1R
Skin and aesthetic regeneration: GHKCu dominates dermal regeneration and hair/skin research, with BPC157 and TB500 augmenting wound closure, vascularization, and reduced scar formation
This sentiment is reflected in the Royal College of Ophthalmologists, the European Association for Diabetic Eye Complications, and the British Clinical Diabetologists statements [54,55] and mirrors evidence for the semaglutide link to diabetic retinopathy [48]